Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas

被引:87
作者
Nabeshima, K
Suzumiya, J
Nagano, M
Ohshima, K
Toole, BP
Tamura, K
Iwasaki, H
Kikuchi, M
机构
[1] Fukuoka Univ, Sch Med, Dept Internal Med, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pathol, Jonan Ku, Fukuoka 8140180, Japan
[3] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Medford, MA 02155 USA
关键词
T-cell lymphoma; invasion; metastasis; matrix metalloproteinase; emmprin;
D O I
10.1002/path.1518
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Degradation of the extracellular matrix by matrix metalloproteinases (MMPs) is a crucial step in tumour invasion and metastasis. In human carcinomas, tumour cell-fibroblast interactions (TFIs) have been demonstrated to play a role in the up-regulation of MMP levels in tumours, and emmprin is a surface molecule on tumour cells that stimulates nearby fibroblasts to produce MMP-1, 2, and 3. T-cell lymphomas frequently show extranodal organ involvement and skin invasion, but a role for TFIs in their invasion has not been examined in detail. This study investigated TFIs in T-cell lymphomas with special reference to emmprin expression and MMP production. Immunohistochemically, only germinal centre cells and some histiocytes expressed emmprin in non-neoplastic lymph nodes (ten cases), while all T-cell lymphomas [14 cases of adult T-cell leukaemia-lymphoma (ATLL), six cases of lymphoblastic lymphoma, seven cases of anaplastic large cell lymphoma, and nine cases of angio-immunoblastic T-cell lymphoma] expressed emmprin strongly and diffusely. FACS analysis of peripheral blood from normal individuals revealed that small fractions of B-cells, T-cells, and monocytes expressed emmprin, whereas emmprin-expressing T-cells were much increased in number, and expressed this protein to a higher level, in ATLL patients. In vitro co-cultures of emmprin-positive HTLV-1-transformed lymphocytes (MT-2) and emmprin-negative human fibroblasts enhanced the production of pro-MMP-2 (gelatinase A) and active MMP-2, compared with cultures of either cell type alone. This stimulation was inhibited by an activity-blocking peptide against emmprin. Moreover, in histopathological sections from patients with ATL skin involvement, MMP-2 was demonstrated in fibroblasts around infiltrating ATL cells, but not in fibroblasts in non-diseased areas. In conclusion, emmprin is overexpressed by T-lymphoma cells, when compared with normal counterparts, and facilitates MMP-2 production via interactions with fibroblasts, which could play a role in stromal invasion by lymphoma cells. Copyright (C) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley Sons, Ltd.
引用
收藏
页码:341 / 351
页数:11
相关论文
共 45 条
  • [1] Albertsson P, 2000, IN VIVO, V14, P269
  • [2] A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS
    BASSET, P
    BELLOCQ, JP
    WOLF, C
    STOLL, I
    HUTIN, P
    LIMACHER, JM
    PODHAJCER, OL
    CHENARD, MP
    RIO, MC
    CHAMBON, P
    [J]. NATURE, 1990, 348 (6303) : 699 - 704
  • [3] BISWAS C, 1995, CANCER RES, V55, P434
  • [4] Bordador LC, 2000, INT J CANCER, V85, P347, DOI 10.1002/(SICI)1097-0215(20000201)85:3<347::AID-IJC9>3.0.CO
  • [5] 2-#
  • [6] ELLIS SM, 1989, CANCER RES, V49, P3385
  • [7] Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines.: A process repressed through RAS/MAP kinase signaling pathways
    Esparza, J
    Vilardell, C
    Calvo, J
    Juan, M
    Vives, J
    Urbano-Márquez, A
    Yagüe, J
    Cid, MC
    [J]. BLOOD, 1999, 94 (08) : 2754 - 2766
  • [8] 5A11 ANTIGEN IS A CELL RECOGNITION MOLECULE WHICH IS INVOLVED IN NEURONAL-GLIAL INTERACTIONS IN AVIAN NEURAL RETINA
    FADOOL, JM
    LINSER, PJ
    [J]. DEVELOPMENTAL DYNAMICS, 1993, 196 (04) : 252 - 262
  • [9] THE MRC-OX-47 ANTIGEN IS A MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY WITH AN UNUSUAL TRANSMEMBRANE SEQUENCE
    FOSSUM, S
    MALLETT, S
    BARCLAY, AN
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (03) : 671 - 679
  • [10] Hauzenberger D, 1999, ANTICANCER RES, V19, P1945